Features of histologiacal morfology of components of the coronary arterial wall in experimental atherosclerosis.

Authors

  • N. S. Tryasak State institution “Dnipropetrovsk medical academy of the Ministry of Health of Ukraine”, Ukraine
  • Yu. V. Silkina State institution “Dnipropetrovsk medical academy of the Ministry of Health of Ukraine”, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2016.3.293-296

Keywords:

coronary vessels, dendritic cells, atherosclerosis, experiment

Abstract

Background. Atherosclerosis is a multifactorial chronic disease, which is associated with immune inflammation of the arteries. The main role in the development of atherosclerotic lesions belongs to the dendritic cells. Objective. To investigate the components of coronary arteries wall and their interrelationships in the experimental atherosclerosis. Methods. Animals received human native low density lipoproteins. Standard histological and immunehistochemical methods were used to detect dendritic cells and other components into coronary arteries wall. Results. On the 4-6th weeks of the experiment it was observed that dendritic cells form contacts with isolated lymphocytes and macrophages, and they were located mainly in the subendothelial layer. On the 12th week the artery wall has changed its structure and the composition of the cellular elements. After 16th week, dendritic cells were found in all layers of the coronary arteries and foam cells were revealed at this period. 18-20th weeks of the experiment were characterized by the phenomena of liposclerosis. Conclusion. It was established that under the normal condition the intima of coronary arteries in rats contains dendritic cells. There is a complex relationships between dendritic cells with other cells. The number of dendritic cells increases with the progression of atherosclerotic lesions. It was observed the redistribution of cells in the intima depends on the stage of atherosclerosis.

References

  1. Nikitin YuP, Dushkin MI, Ragino YuI, editors. [Some molecular and biological mechanisms of atherosclerosis]. Atherosclerosis. 2008;(1):3-10. Russian.
  2. Karagodin VP, Bobryshev YV, Kovalevskaya Zh. [Cellular mechanisms of atherosclerosis: innate immunity and inflammation]. Basic science and practice. 2010;1(4):140-8. Russian.
  3. Nagornev VA. [Methodology in the study of atherosclerosis]. Medical academic journal. 2005;5(3):121-33. Russian.
  4. Yuzhik EI, Lushnikova EL. [Medico-biological aspects of modeling of the atherosclerotic process]. Fundamental research. 2012;(10):176-83. Russian.
  5. Klimov AN, Nagornev VA. Evolution of cholesterol concept of atherogenesis from Anitchkov to our days. Pediatric pathology and molecular medicine. 2002;21(3):307-20.
  6. Shimada K. Immune system and atherosclerotic disease: heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis. Circulation. 2009;73:994-1001.
  7. Menshikov IV, Makarova MI. [Autoimmune reaction in the pathogenesis of atherosclerosis]. Immunology. 2010;(5):242-6. Russian.
  8. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annual Review of Immunoly. 2003;21:685-711.
  9. Bobryshev YV, Lord RS. Structural heterogeneity and contacting interactions of vascular dendritic cells in early atherosclerotic lesions of the human aorta. Journal of Submicroscopic Cytology and Pathology. 1996;(6):49-60.
  10. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiological Reviews. 2002;82:97-130.
  11. Bobryshev YV, Orekhov AN. [Dendritic cells in atherogenesis: Identification and pathophysiological significance]. Pathogenesis. 2013;11(1): 6-15. Russian.
  12. Bobryshev YV, Lord RS. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovascular research. 1998;37:799-810.
  13. Hansson GK. Immune mechanisms in atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology. 2001;21:1876-1890.
  14. Bobryshev YV, Taksir T, Lord RS, Free-man MW. Evidence that dendritic cells infiltrate atherosclerotic lesions in apolipoprotein E-deficient mice. Histology and Histopathology. 2001;16:801-8.
  15. Wick G, Romen M, Amberger A. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. The FASEB Journal. 1997;11(13):1199-207.
  16. Sharma R, Li DZ. Role of dendritic cells in atherosclerosis. Asian Cardiovasсular &Thoracic Annals. 2006;14:166-9.
  17. Link A, Böhm M. Potential role of dendritic cells in atherogenesis. Cardiovascular Research. 2002;55:708-9.
  18. Manthey HD, Zernecke А. Dendritic cells in atherosclerosis: Functions in immune regulation and beyond. Journal of Thrombosis and Haemosta-sis. 2011;106:772-8.
  19. Menshikov IV, Fomina KV, Beduleva LV. [A new experimental murine model of atherosclerosis by immunization with human native low-density lipoproteins]. Bulletin of Udmurt University. 2012;1:80-6. Russian.
  20. Virela G, Lopes-Virela MF. Atherogenesis and the humoral immune response to modified lipoproteins. Atherosclerosis. 2008;2:239-46.
  21. Khlyustov VN. [Quantitative determination of autoantibodies to low-density lipoprotein]. Clinical laboratory diagnostics. 1999;4:17-20. Russian.
  22. Bobryshev YV, Lord RS. S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovascular Research. 1995;4:689-96.
  23. Frostegard J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmunity Reviews. 2002; 2(3):233-7.

How to Cite

Tryasak, N. S., & Silkina, Y. V. (2016). Features of histologiacal morfology of components of the coronary arterial wall in experimental atherosclerosis. Морфологія / Morphologia / Morfologìâ, 10(3), 293–296. https://doi.org/10.26641/1997-9665.2016.3.293-296

Issue

Section

Статті